Navigation Links
Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
Date:10/25/2007

"We look forward to future research efforts to further elucidate the role of AGEs in gastrointestinal complications including diabetic intestinal dysfunction, diabetic enteropathy and diabetic gastroparesis and the role that alagebrium may play in those disease."

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing small molecule drugs to treat and prevent cardiovascular disease and to treat nephropathy in people with diabetes. The Company has identified several product candidates that it believes represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxidase. These compounds metabolize lipid peroxides and have the potential to limit myocardial damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment, using Haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes.

Synvista Therapeutics also is developing alagebrium, a proposed breaker of AGEs for the treatment of diastolic heart failure. This disease represents a rapidly growing market of unmet medical need, particularly common among diabetic patients. Alagebrium has demonstrated relevant clinical activity in two Phase 2 clinical trials in heart failure, as well as in animal models of heart failure and nephropathy, among others. Alagebrium has been tested in approximately 1,000 patients in multiple Phase 1 and Phase 2 clinical trials, allowing Synvista Therapeutics to assemble a sizeable human safety database. For more information, please visit the Company's website at http://www.synvista.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties in
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... More than a third of reproductive-aged women enrolled in ... insurance, filled a prescription for an opioid pain medication each ... Morbidity and Mortality Weekly Report (MMWR). Opioids ... to severe pain.  They are also found in some prescription ...
(Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
(Date:1/23/2015)... Inc., a leader in hand hygiene monitoring, today announced ... subsidiary of Ascendis Health Limited, in Johannesburg, ... of millions of patients around the world are affected ... patient to patient via the unwashed hands of healthcare ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... 9, 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: ... third quarter ended September 30, 2011. (Logo: ... third quarter of 2011 were $83.8 million, compared to $86.4 ... year-over-year decrease. Total revenues for the nine months ended September ...
... Nov. 9, 2011 Volcano Corporation (NASDAQ: ... guidance therapy tools designed to enhance the treatment of ... Intravascular Ultrasound (IVUS) and Fractional Flow Reserve (FFR) technologies ... patients undergoing percutaneous coronary intervention (PCI). The update was ...
Cached Medicine Technology:PDL BioPharma Announces Third Quarter 2011 Financial Results 2PDL BioPharma Announces Third Quarter 2011 Financial Results 3PDL BioPharma Announces Third Quarter 2011 Financial Results 4PDL BioPharma Announces Third Quarter 2011 Financial Results 5PDL BioPharma Announces Third Quarter 2011 Financial Results 6PDL BioPharma Announces Third Quarter 2011 Financial Results 7PDL BioPharma Announces Third Quarter 2011 Financial Results 8PDL BioPharma Announces Third Quarter 2011 Financial Results 9PDL BioPharma Announces Third Quarter 2011 Financial Results 10PDL BioPharma Announces Third Quarter 2011 Financial Results 11Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcano's Precision Guided Therapy Technologies 2Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcano's Precision Guided Therapy Technologies 3
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Thousand of ... Medical Care recalled its GranuFlo and NaturaLyte dialysis concentrates ... underway in U.S. District Court, District of Massachusetts, Bernstein ... 20th, the Court has remanded a case filed by ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Payday lending ... vulnerable communities and cause financial distress to the states ... analysts at Howard University’s Center on Race and Wealth. ... in economic activity, payday loans at the same time ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the importance ... reducing the costs of an auto insurance policy . , ... lower prices for their vehicle insurance policies. The safety a vehicle ... costs. Because of this, drivers should always carry a first ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... 2009, New York, NY / Los Angeles, CA: ... groundbreaking research aimed at getting new cancer treatments to ... milestone, awarding the first round of three-year grants ... research Dream Teams. The majority of these funds were ...
... Scientists, Engineers and Professionals Slated for Tuesday through Thursday November ... ... Boston, MA (PRWEB) May 27, 2009 -- ... online events for the healthcare, education and energy markets, and ...
... 27 Allscripts announced today that Southwest General ... Professional(R) Electronic Health Record (EHR) for ... suburban Cleveland, Ohio. (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO )SGHC ... center with its own physician group, outpatient clinics ...
... announced today that it has developed the ... healthcare education program for patients and their caregivers."As many ... can lead to poor outcomes," said CMPMedica CEO Sally ... educational information to bridge those gaps can improve adherence ...
... adds value-driven Quality Health First program as a ... Providing more Hoosiers with an innovative approach ... a third party administrator, is participating in the ... (QHF) program, which helps physicians and patients achieve ...
... to Help Parents and Kids to a Full ... nickname for summertime in the nation,s hospitals. Warmer weather ... million children under the age of 15 into emergency ... most common injuries are motor vehicle crashes, water-related accidents, ...
Cached Medicine News:Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 2Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 3Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 4Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 5Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 6Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 7Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 8Health News:PlatformQ and LabRoots Announce BioConference Live, Online Conference for the Life Science Research and Laboratory Sciences Community 2Health News:PlatformQ and LabRoots Announce BioConference Live, Online Conference for the Life Science Research and Laboratory Sciences Community 3Health News:Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record 2Health News:Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record 3Health News:Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record 4Health News:Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record 5Health News:CMPMedica Announces the Health Empowerment Initiative 2Health News:CMPMedica Announces the Health Empowerment Initiative 3Health News:Unified Group Services Participates in Indiana Health Information Exchange's Innovative Quality Reporting and Healthcare Disease Management Service 2Health News:Unified Group Services Participates in Indiana Health Information Exchange's Innovative Quality Reporting and Healthcare Disease Management Service 3Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 3
... and ETS-FLEX45 Endoscopic Linear Cutters provide a ... shaft length makes the device suitable for ... are intended for transection, resection, and/or creation ... invasive surgical procedures., ,The LONG45A Endocutter ...
ENDO CLIP II ML, 10 mm Pistol Grip Single Use Clip Applier with Medium - Large Super Interlock Titanium Clips...
... is designed with opposing male/female interlocking features. ... and improved hemostasis., ,By comparison, The ... percent greater angle allowing for maximum visibility ... ELC has an automatic, direct drive clip ...
Pilling-Weck, medium clip size, 10mm, rotatable take apart...
Medicine Products: